CD4 and acute myeloid leukemia: The extent to which the findings of this study can serve as predictors of CAR T therapy efficacy in AML patients, or whether mitochondrial functional genes expressed explicitly by CD4+ Tcm cells may represent viable targets for CAR T therapy, necessitates further investigation supported by subsequent experiments and clinical data.